APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome

about

APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates

P2860

Q58547737-7D154D7F-599E-4A24-B5BA-AB0F2D94BA6F

P2860

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome

Item

http://www.wikidata.org/entity/Q38663579

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

APOE genotype influences insul ...... file in the Metabolic Syndrome

@en

type

Item

label

APOE genotype influences insul ...... file in the Metabolic Syndrome

@en

prefLabel

APOE genotype influences insul ...... file in the Metabolic Syndrome

@en

P1476

APOE genotype influences insul ...... file in the Metabolic Syndrome

@en

P2093

Aldona Dembińska-Kieć

http://www.w3.org/2001/XMLSchema#string

Andrew L Carvalho-Wells

http://www.w3.org/2001/XMLSchema#string

Audrey C Tierney

http://www.w3.org/2001/XMLSchema#string

Beata Kieć-Wilk

http://www.w3.org/2001/XMLSchema#string

Carmen Marin

http://www.w3.org/2001/XMLSchema#string

Catherine DeFoort

http://www.w3.org/2001/XMLSchema#string

Ellen E Blaak

http://www.w3.org/2001/XMLSchema#string

José Lopez-Miranda

http://www.w3.org/2001/XMLSchema#string

Rosalind Fallaize

http://www.w3.org/2001/XMLSchema#string

Wim H Saris

http://www.w3.org/2001/XMLSchema#string

P2860

Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials

Reduction in saturated fat intake for cardiovascular disease

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?

Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Association of apolipoprotein E genotypes with lipid levels and coronary risk

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

P2888

s41598-017-05802-2

P304

6274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-05802-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090780662

http://www.w3.org/2001/XMLSchema#string

P698

28740125

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

metabolic syndrome

P932

5524844

http://www.w3.org/2001/XMLSchema#string

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome

about

P2860

P2860

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932